Probiotics for the prevention or treatment of hyperbilirubinaemia in late preterm and term neonates

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the safety and efficacy of probiotics supplementation in preventing hyperbilirubinaemia among late preterm (born at gestational age (GA) 34 weeks to 36 weeks and six days) and term neonates (≥ 37 wee...

Full description

Saved in:
Bibliographic Details
Published in:Cochrane database of systematic reviews 2017-08, Vol.2017 (8)
Main Authors: Sinha, Anju, Pradhan, Alok, Thumburu, Kiran K, Gupta, Neeraj
Format: Article
Language:English
Subjects:
Medicine General & Introductory Medical Sciences
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the safety and efficacy of probiotics supplementation in preventing hyperbilirubinaemia among late preterm (born at gestational age (GA) 34 weeks to 36 weeks and six days) and term neonates (≥ 37 weeks) To determine the safety and efficacy of probiotics supplementation in treating hyperbilirubinaemia among late preterm (born at 34 weeks to 36 weeks and six days) and term neonates (≥ 37 weeks) Subgroup analyses will include gestational age at birth (term vs late preterm), cause of jaundice (haemolytic vs non‐haemolytic jaundice), mode of feeding at the time of enrolment (exclusive breastfeeding vs mixed feeding/formula feeding), and types of probiotics used.
ISSN:1469-493X
DOI:10.1002/14651858.CD012781